Search
for

    Sort by

    Research 871–900 of 1000+

    1. Transcriptome Profiling of Human Follicle Dermal Papilla Cells in response to Porphyra-334 Treatment by RNA-Seq Evidence-based complementary and alternative medicine · 2021 · 7 citations
    2. Regulatory T cell dysfunction and immunotherapeutic breakthroughs in type 1 diabetes Frontiers in Endocrinology · 2026 · 2 citations
    3. Human Liver MSCs Retain Their Basic Cellular Properties in Chronically Inflamed Liver Tissue International Journal of Molecular Sciences · 2024 · 2 citations
    4. RSPO1, a potent inducer of pancreatic β cell neogenesis Cell Reports Medicine · 2025 · 1 citations
    5. Topological Distribution of Wound Stiffness Modulates Wound-Induced Hair Follicle Neogenesis Pharmaceutics · 2022 · 1 citations
    6. Molecular cytokine-dependent mechanisms of periodontitis pathogenesis and the potential for pharmacological IL-1 modulation in disease treatment Frontiers in Dental Medicine · 2026
    7. IL-33 Contributes to the Pathological Changes of Hair Follicles in Psoriasis: A Potential Target for Psoriatic Alopecia Clinical, cosmetic and investigational dermatology · 2023
    8. Highlights from the Literature Physiology · 2005
    9. Genetics of Diabetes in Childhood Springer eBooks · 2003
    10. Circulating and/or cutaneous irisin resistance: A novel link among androgenetic alopecia, comorbid metabolic syndrome and cardiovascular risks Journal of Cosmetic Dermatology · 2023
    11. Unscrewing DHT-Blocking Properties of Allium Cepa Extract: Virtual Screening of active Compounds against 5-Alpha Reductase and Evaluation of Adme/T Properties of Compounds Zenodo (CERN European Organization for Nuclear Research) · 2023 · 1 citations
    12. A Review on Curcumin-Piperine Synergy in Alopecia: Phytochemical Profiling, Molecular Docking and Network Pharmacology Approaches Zenodo (CERN European Organization for Nuclear Research) · 2026
    13. A Review on Curcumin-Piperine Synergy in Alopecia: Phytochemical Profiling, Molecular Docking and Network Pharmacology Approaches Zenodo (CERN European Organization for Nuclear Research) · 2026
    14. In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling Zenodo (CERN European Organization for Nuclear Research) · 2026
    15. In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling Zenodo (CERN European Organization for Nuclear Research) · 2026
    16. Methods for Treating Androgenic Alopecia by Restoration of Morphogenetic Field Connectivity in Hair Follicle Networks Zenodo (CERN European Organization for Nuclear Research) · 2026
    17. Trazodone and chlorpromazine a proposal treatment for syndrome post-finasteride and syndrome of post-selective serotonin reuptake inhibitors (post-SSRI) Zenodo (CERN European Organization for Nuclear Research) · 2023
    18. Probiotics: An Adjuvant therapy for D-Galactose induced Alzheimer's disease Zenodo (CERN European Organization for Nuclear Research) · 2017
    19. Epidemiology, Genetics & Risk factors in Alopecia Androgenetics Zenodo (CERN European Organization for Nuclear Research) · 2026
    20. Epidemiology, Genetics & Risk factors in Alopecia Androgenetics Zenodo (CERN European Organization for Nuclear Research) · 2026
    21. The Hair Follicle and Hair Loss: A Review of DHT, Inflammation, Oxidative Stress, Vascular Signalling and the Biological Pathways Behind Hair Growth Zenodo (CERN European Organization for Nuclear Research) · 2026
    22. The Hair Follicle and Hair Loss: A Review of DHT, Inflammation, Oxidative Stress, Vascular Signalling and the Biological Pathways Behind Hair Growth Zenodo (CERN European Organization for Nuclear Research) · 2026
    23. Multi-target evaluation of Korean herbal compounds against the SRD5A2 / AR / beta-catenin axis for androgenetic alopecia: Boltz-2 cofold, ChEMBL-anchored ranking, ADMET-AI 107-endpoint safety panel, and pilosebaceous single-cell atlas-constrained prioritization of Saponin Re, Emodin, and Biochanin A Zenodo (CERN European Organization for Nuclear Research) · 2026
    24. ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability Zenodo (CERN European Organization for Nuclear Research) · 2026
    25. ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability Zenodo (CERN European Organization for Nuclear Research) · 2026
    26. Nutritional Pharmacology and Mechanistic Insights of Saw Palmetto in Male Endocrine and Prostatic Disorders Zenodo (CERN European Organization for Nuclear Research) · 2025
    27. Nutritional Pharmacology and Mechanistic Insights of Saw Palmetto in Male Endocrine and Prostatic Disorders Zenodo (CERN European Organization for Nuclear Research) · 2025
    28. Low Level Laser Treatment for Patterned Hair Loss: A Systematic Review Zenodo (CERN European Organization for Nuclear Research) · 2018
    29. Dermatological alterations induced by gynecological hormonal imbalances: Acne, hirsutism and alopecia Zenodo (CERN European Organization for Nuclear Research) · 2025
    30. Dermatological alterations induced by gynecological hormonal imbalances: Acne, hirsutism and alopecia Zenodo (CERN European Organization for Nuclear Research) · 2025